Impact of clinical decision support preventing the use of QT-prolonging medications for patients at risk for torsade de pointes

Journal of the American Medical Informatics Association

Volumn 22, Issue e1, 2015, Pages e21-e27

  Sorita, Atsushi ^a   Bos, J Martijn ^a   Morlan, Bruce W ^a   Tarrell, Robert F ^a   Ackerman, Michael J ^a,b   Caraballo, Pedro J ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Clinical decision support; Computerized physician order entry; Medication management; QT prolongation; Torsade de pointes

Indexed keywords

ADULT; ARTICLE; CLINICAL DECISION SUPPORT SYSTEM; CLINICAL PRACTICE; COMPUTERIZED PROVIDER ORDER ENTRY; EDUCATIONAL STATUS; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICATION THERAPY MANAGEMENT; OUTCOME ASSESSMENT; QT PROLONGATION; TORSADE DES POINTES; AGED; COMPLICATION; COMPUTER ASSISTED DRUG THERAPY; DEATH, SUDDEN, CARDIAC; DRUG EFFECTS; ELECTROCARDIOGRAPHY; LONG QT SYNDROME; MIDDLE AGED; PHYSICIAN ORDER ENTRY SYSTEM; RISK FACTOR; TORSADES DE POINTES;

AGED; DEATH, SUDDEN, CARDIAC; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG THERAPY, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MEDICAL ORDER ENTRY SYSTEMS; MIDDLE AGED; RISK FACTORS; TORSADES DE POINTES;

EID: 84986888976     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1136/amiajnl-2014-002896     Document Type: Article

References (23)

1. Hobbs JB, Peterson DR, Moss AJ, et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA. 2006;296:1249-54.
2. Montanez A, Ruskin JN, Hebert PR, et al. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med. 2004;164:943-8.
3. Straus SM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47:362-7.
4. Zhang Y, Post WS, Blasco-Colmenares E, et al. Electrocardiographic QT interval and mortality: a meta-analysis. Epidemiology. 2011;22:660-70.
5. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:225-35.
6. Ray WA, Murray KT, Hall K, et al. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366:1881-90.
7. Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2010; 55:934-47.
8. Fongemie JM, Al-Qadheeb NS, Estes NAIII, et al. Agreement between ICU clinicians and electrophysiology cardiologists on the decision to initiate a QTc-interval prolonging medication in critically ill patients with potential risk factors for torsade de pointes: a comparative, case-based evaluation. Pharmacotherapy. 2013;33:589-97.
9. First Databank. http://www.fdbhealth.com/
10. Haugaa KH, Bos JM, Tarrell RF, et al. Institution-wide QT alert system identifies patients with a high risk of mortality. Mayo Clin Proc. 2013;88:315-25.
11. AZCERT. CredibleMeds. http://crediblemeds.org/.
12. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2011.
13. Kawamoto K, Houlihan CA, Balas EA, et al. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330:765.
14. Weingart SN, Toth M, Sands DZ, et al. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med. 2003;163:2625-31.
15. Embi PJ, Leonard AC. Evaluating alert fatigue over time to EHR-based clinical trial alerts: findings from a randomized controlled study. J Am Med Inform Assoc. 2012; 19(e1):e145-8.
16. Bright TJ, Wong A, Dhurjati R, et al. Effect of clinical decision-support systems: a systematic review. Ann Intern Med. 2012;157:29-43.
17. Wolfstadt JI, Gurwitz JH, Field TS, et al. The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med. 2008;23:451-8.
18. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med. 2003;163:1409-16.
19. Blumenthal D, Tavenner M. The "meaningful use" regulation for electronic health records. N Engl J Med. 2010;363: 501-4.
20. HealthIT.gov. How to Attain Meaningful Use. http://www. healthit.gov/providers-professionals/how-attain-meaningful-use
21. Sommargren CE, Drew BJ. Preventing torsades de pointes by careful cardiac monitoring in hospital settings. AACN Adv Crit Care. 2007;18:285-93.
22. Slama TG. Minimizing the risk for QT interval prolongation. J Fam Pract. 2005;54(Suppl):S15-17.
23. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48: e247-346.